- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07941817
Using Narrative Exposure Therapy to Treat Violent Offenders With Post Traumatic Stress and Emotion Dysregulation.
Using Narrative Exposure Therapy to Treat Violent Offenders With Post Traumatic Stress and Emotion Dysregulation: A Single Case Study Series.
The purpose of this study is to find out whether a therapy called Narrative Exposure Therapy (NET) is suitable and could be helpful for people who:
- have experienced trauma
- find it hard to manage their emotions
- have a history of violent offending
NET is already used in clinical practice, but there is limited research about how helpful it is for this group. This study will look at whether NET:
- is feasible to use in this population
- reduces symptoms of post-traumatic stress (such as nightmares, flashbacks, and feeling on edge)
- helps people manage their emotions better What is NET? NET is a one-to-one talking therapy for people who have experienced trauma. In NET, the patient and the therapist create a timeline of your life. This includes both positive experiences and difficult or traumatic events. individuals then talk through the traumatic events in a safe and structured way, with support from the therapist.
The aim is to help the brain process these memories so they cause less distress in everyday life. NET focuses on you as a whole person, not just on your offending history.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Trauma, emotion regulation and offending Individuals within the offending population have experienced more adverse childhood experiences (ACE's) and traumatic life events than those within the general population, indicating that experiences of post-traumatic stress may be more prevalent within this group when compared to the prevalence in the general population. Despite this, diagnosis of Post Traumatic Stress Disorder often goes undiagnosed and untreated within the offending population.
Emotion Regulation is defined as the ability to inhibit and maintain emotional expressions. ICD - 11 indicates for a diagnosis for Complex Post Traumatic Stress Disorder there should be difficulties in emotion regulation present . This is further evidenced by Cloitre et.al. who indicated that Adverse Childhood Experiences and prolonged trauma in childhood may lead to difficulties in emotion regulation. Thus, if levels of ACE's and traumatic life events are more prevalent in offending populations, this may indicate potential difficulties in emotion regulation.
Post traumatic stress and Heart Rate Variability (HRV) Post Traumatic Stress is identified as a cluster of symptoms that are associated with the diagnosis of PTSD. These symptoms include intrusions such as flashbacks and nightmares, avoidance, changes in cognition and mood such as negative thoughts about self or the world and arousal and reactivity for example being easily startled or on edge. Despite the experience of post traumatic stress being common in offending populations, PTSD often goes undiagnosed.
HRV refers to the fluctuation of heart rate over a period and is used as a physiological marker of mental wellbeing. HRV reflects the balance of the sympathetic and parasympathetic systems held within the autonomic nervous system. An increase in anxiety is reflected in reduced HRV, which indicates an increase in heart rate meaning that the sympathetic and parasympathetic systems are in acting parsimoniously. The ICD-10 recognises increased arousal as a post traumatic stress symptom, indicating increases in anxiety are related to post traumatic stress, thus reduced HRV. Research has shown alterations in HRV among individuals with PTSD, specifically, PTSD has been associated with reduced HRV, similar to the findings with anxiety. The reduced HRV observed in PTSD patients may be a physiological manifestation of this heightened stress state that is associated with post-traumatic stress. Thus, measuring HRV is a sufficient way of measuring distress associated with post - traumatic stress via physiological symptomology which is less subjective.
What is Narrative Exposure Therapy? Narrative Exposure Therapy (NET) is a short-term specific trauma therapy recommended by the National Institute for Health and Care Excellence (NICE) for work with refugees. NET was developed based on experiences seen in refugees and victims of torture. The researchers found that developing a narrative timeline of the victim's trauma, helped reduce post-traumatic stress symptoms and increased hope. In NET, individuals talk through a chronological narrative timeline of their life experiences, with the aim to reconstruct fragmented trauma memories into coherent narrative memories that are contextualised in the time and space that they originally happened. This is achieved by tapping into the fear network, the cognitive, emotional and sensory bodily memories of the trauma and connecting these memories to the chronological time that they happened, allowing for processing of the trauma memory and a more coherent, less fragmented life story being formed. Patients are encouraged to relive the emotions felt by the memory whilst staying connected to the present thus reminding the patient that the feelings are because of the memory, making episodic links to "then" and "now" . Furthermore, NET also works on the process of habituation, which means exposing yourself to the trauma memory, not avoiding it. This allows individuals to change their beliefs about the trauma memory by learning that the anxiety they feel when exposed to the memory will reduce (Lord, 2023), thus they will habituate to the memory.
Previous Research in NET NET has an increasing evidence base across various populations and has gained support in its treatment for CPTSD. NET has been shown to be potentially effective in reducing post-traumatic stress in various populations including refugees, women who have experienced Interpersonal Violence and veterans. An adapted version of NET (FORNET) has been shown to be a superior treatment in improving PTSD, aggression and depression in child soldiers. Thus, research has indicated the use of NET may be appropriate for those who have experienced traumatic life events and have potentially committed violence within the past. There is little evidence supporting the use of non-adapted NET in adults who have offended, thus further research is needed to investigate whether NET would be helpful in this population.
NET has also been evidenced to have less attrition than other trauma therapies when working with individuals with complex trauma histories, and NET is seen as the superior treatment for these individuals, this suggests that NET may be beneficial for those with complex trauma such as ACE's and interpersonal childhood trauma, which is often seen in offending populations.
Rationale for study This research aims to inform the growing research base of using NET within various populations. The results of this research have implications for further research into using NET within this population, which could indicate other potential positive outcomes such as decreased reoffending and use of services, which would decrease burden on already overstretched services. Despite the lack of research into using Narrative Exposure Therapy within offending populations, the intervention is starting to be used in practice and therefore research into this area is important to inform evidence-based practice. Furthermore, a lot of treatment focus for offenders is on managing forensic risk and is not person centred, often leaving the individual feeling that what has happened to them is not important. Research suggests that post traumatic stress is a risk factor for violent behaviour, thus indicating that a focus on trauma rather than risk may be beneficial for those who have committed violent offences in reducing risk but also improving mental wellbeing. Moreover, as NET encourages a complete view of a person's timeline, not just highlighting negative events but positive life events too, this minimises the emphasis on solely negative life experiences. This allows individuals to consider positives parts of their lives, rather than just negative life events and trauma, which is often a difficulty experienced in forensic populations due to the nature of the population
The purpose of this investigation is to understand whether NET is feasible to use within the population of violent offenders. We aim to investigate this by looking at its impact on experiences of post - traumatic stress and ability to regulate emotion. We also aim to look at participant experiences of NET, to inform whether this intervention is acceptable to use in this population and is accessible for them. This knowledge would inform further investigations into the potential effectiveness of NET within this population.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Rebecca Watson
- Número de telefone: 07727734021
- E-mail: 29629374@students.lincoln.ac.uk
Estude backup de contato
- Nome: Thomas Schroder, Professor
- E-mail: Thomas.Schroder@nottingham.ac.uk
Locais de estudo
-
-
-
Lincoln, Reino Unido
- Recrutamento
- Community Forensic Team
-
Contato:
- Mary Jinks
- E-mail: mary.jinks@nhs.net
-
Investigador principal:
- Rebecca Watson
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Over 18 years
- Can communicate and understand English independently, in a way that would meet the B2 reference level in the CEFR global scale
- Experiencing post-traumatic stress or diagnosed with PTSD
- Has difficulties regulating emotions assessed as in clinical assessment from the Community Forensic Team
- Have committed a violent offence which they have been charged with.
Exclusion Criteria:
- Anyone who is presenting as acutely unwell, or struggling with active suicidal ideation, with plans and intent. Due to the nature of the therapy as stated above, and exposure to memories of potentially traumatic life events, it would not be suitable to conduct the therapy with those presenting with active risk to self.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Narrative Exposure Therapy Treatment
Participants will receive narrative exposure therapy |
Narrative Exposure Therapy |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
International Trauma Questionnaire
Prazo: From enrolment to the end of treatment. 3 week baseline Phases starting from Week 1, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.
|
Trauma Questionnaire that is based on the ICD 11 criteria for PTSD diagnosis. It is a Likert scale with scores ranging from 0-5. The higher the score the more symptoms individuals have. |
From enrolment to the end of treatment. 3 week baseline Phases starting from Week 1, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Difficulties in Emotion Regulation Scale -16
Prazo: Before intervention at week 2 of the baseline phase and after intervention on the final session which could be up to session 20.
|
A measure of emotion regulation. It is a Likert scale indicating with scores from 0-5, with higher scores indicating more difficulties in emotion regulation. |
Before intervention at week 2 of the baseline phase and after intervention on the final session which could be up to session 20.
|
|
CORE-10
Prazo: From enrolment to the end of treatment. 3 week baseline Phases starting from Week 1, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.
|
A measure of general wellbeing. A likert scale with scores from 0-5 with higher scores indicating worse overall wellbeing and lower scores indicating better overall wellbeing |
From enrolment to the end of treatment. 3 week baseline Phases starting from Week 1, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.
|
|
Heart Rate Variability
Prazo: To be administered after the 3 week baseline Phases, when trauma processing commences, starting from Week 2 of the experimental phase, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.
|
To be administered after the 3 week baseline Phases, when trauma processing commences, starting from Week 2 of the experimental phase, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Rebecca Watson, University of Lincoln
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- ULincoln
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .